肥胖型多囊卵巢综合征患者血清左旋肉毒碱水平的变化及意义(4)
[14] McCoin CS，Knotts TA，Adams SH. Acylcarnitines——old actors auditioning for new roles in metabolic physiology [J]. Nat Rev Endocrinol，2015，11(10)：617-625.
[15] Moghetti P. Insulin resistance and polycystic ovary syndrome [J]. Curr Pharm Des，2016，22(36)：5526-5534.
[16] Pauli JM，Raja-Khan N，Wu X，et al. Current perspectives of insulin resistance and polycystic ovary syndrome [J]. Diabet Med，2011，28(12)：1445-1454.
[17] Sirmans SM，Pate KA. Epidemiology，diagnosis，and management of polycystic ovary syndrome [J]. Clin Epidemiol，2013，6(1)：1-13.
[18] Ruggenenti P，Cattaneo D，Loriga G，et al. Ameliorating hypertension and insulin resistance in subjects at increased cardiovascular risk：effects of acetyl-L-carnitine therapy [J]. Hypertension，2009，54(3)：567-574.
[19] Power RA，Hulver MW，Zhang JY，et al. Carnitine revisited：potential use as adjunctive treatment in diabetes [J]. Diabetologia，2007，50(4)：824-832.
[20] Vidal-Casariego A，Burgos-Peláez R，Martínez-Faedo C，et al. Metabolic effects of L-carnitine on type 2 diabetes mellitus：systematic review and meta-analysis [J]. Exp Clin Endocrinol Diabetes，2013，121(4)：234-238.
[21] Fenkci SM，Fenkci V，Oztekin O，et al. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome [J]. Hum Reprod，2008，23(7)：1602-1606.
(收稿日期：2017-01-09 本文編辑：李亚聪), 百拇医药(王菲 刘亚萍)
[15] Moghetti P. Insulin resistance and polycystic ovary syndrome [J]. Curr Pharm Des，2016，22(36)：5526-5534.
[16] Pauli JM，Raja-Khan N，Wu X，et al. Current perspectives of insulin resistance and polycystic ovary syndrome [J]. Diabet Med，2011，28(12)：1445-1454.
[17] Sirmans SM，Pate KA. Epidemiology，diagnosis，and management of polycystic ovary syndrome [J]. Clin Epidemiol，2013，6(1)：1-13.
[18] Ruggenenti P，Cattaneo D，Loriga G，et al. Ameliorating hypertension and insulin resistance in subjects at increased cardiovascular risk：effects of acetyl-L-carnitine therapy [J]. Hypertension，2009，54(3)：567-574.
[19] Power RA，Hulver MW，Zhang JY，et al. Carnitine revisited：potential use as adjunctive treatment in diabetes [J]. Diabetologia，2007，50(4)：824-832.
[20] Vidal-Casariego A，Burgos-Peláez R，Martínez-Faedo C，et al. Metabolic effects of L-carnitine on type 2 diabetes mellitus：systematic review and meta-analysis [J]. Exp Clin Endocrinol Diabetes，2013，121(4)：234-238.
[21] Fenkci SM，Fenkci V，Oztekin O，et al. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome [J]. Hum Reprod，2008，23(7)：1602-1606.
(收稿日期：2017-01-09 本文編辑：李亚聪), 百拇医药(王菲 刘亚萍)